Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | D07AC17 |
InChI Key | MGNNYOODZCAHBA-GQKYHHCASA-N |
---|---|
Smile | |
InChI |
|
Mesh Heading | Maximum Phase | Reference |
---|---|---|
Psoriasis | Phase 4 | ClinicalTrials |
Asthma; Inflammation | Phase 4 | ClinicalTrials |
Asthma | Phase 2 | ClinicalTrials |
Inflammation; Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive | Phase 4 | ClinicalTrials |
Asthma | Phase 4 | ClinicalTrials |
Respiratory Aspiration | Phase 1 | ClinicalTrials |
Asthma | Phase 4 | ClinicalTrials |
Asthma | Phase 2 | ClinicalTrials |
Asthma | Phase 2 | ClinicalTrials |
Rhinitis; Rhinitis, Allergic | Phase 2 | ClinicalTrials |
Pulmonary Disease, Chronic Obstructive | Phase 2 | ClinicalTrials |
Eosinophilic Esophagitis; Esophagitis | Phase 4 | ClinicalTrials |
Eosinophilic Esophagitis; Esophagitis | Phase 4 | ClinicalTrials |
Asthma | Phase 4 | ClinicalTrials |
Rhinitis; Rhinitis, Allergic | Phase 1 | ClinicalTrials |
Asthma | Phase 3 | ClinicalTrials |
Eosinophilic Esophagitis; Esophagitis | Phase 2 | ClinicalTrials |
Rhinitis; Rhinitis, Allergic; Rhinitis, Allergic, Perennial | Phase 3 | ClinicalTrials |
Asthma | Phase 4 | ClinicalTrials |
Asthma | Phase 3 | ClinicalTrials |
Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive | Phase 4 | ClinicalTrials |
Asthma | Phase 4 | ClinicalTrials |
Eosinophilic Esophagitis; Esophagitis | Phase 3 | ClinicalTrials |
Eosinophilic Esophagitis; Esophagitis | Phase 2 | ClinicalTrials |
Asthma | Phase 3 | ClinicalTrials |
Asthma | Phase 2 | ClinicalTrials |
Croup | Phase 3 | ClinicalTrials |
Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive | Phase 2 | ClinicalTrials |
Asthma | Phase 3 | ClinicalTrials |
Asthma | Phase 4 | ClinicalTrials |
Lung Diseases; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive | Phase 1 | ClinicalTrials |
Conjunctivitis; Conjunctivitis, Allergic | Phase 4 | ClinicalTrials |
Rhinitis; Rhinitis, Allergic; Rhinitis, Allergic, Perennial | Phase 3 | ClinicalTrials |